These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 36826143)

  • 1. Tumors of the Digestive System: Comprehensive Review of Ancillary Testing and Biomarkers in the Era of Precision Medicine.
    Molnar A; Monroe H; Basri Aydin H; Arslan ME; Lightle A; Lee H; El Jabbour T
    Curr Oncol; 2023 Feb; 30(2):2388-2404. PubMed ID: 36826143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research Progress of Biomarkers for Immune Checkpoint Inhibitors on Digestive System Cancers.
    Wang J; Ma X; Ma Z; Ma Y; Wang J; Cao B
    Front Immunol; 2022; 13():810539. PubMed ID: 35493526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune response and digestive cancers: Prognostic and therapeutic implications].
    Bibeau F; Bazille C; Svrcek M; Pierson R; Lagorce-Pagès C; Cohen R; André T
    Ann Pathol; 2017 Feb; 37(1):111-116. PubMed ID: 28111038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers.
    Eso Y; Shimizu T; Takeda H; Takai A; Marusawa H
    J Gastroenterol; 2020 Jan; 55(1):15-26. PubMed ID: 31494725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Testing for the Treatment of Advanced Colorectal Cancer: An Overview.
    Lin PS; Semrad TJ
    Methods Mol Biol; 2018; 1765():281-297. PubMed ID: 29589315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer.
    Zang YS; Dai C; Xu X; Cai X; Wang G; Wei J; Wu A; Sun W; Jiao S; Xu Q
    Cancer Med; 2019 Aug; 8(10):4699-4708. PubMed ID: 31270941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive biomarkers for personalized medicine in breast cancer.
    Rodrigues-Ferreira S; Nahmias C
    Cancer Lett; 2022 Oct; 545():215828. PubMed ID: 35853538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin‑conjugating enzymes as potential biomarkers and therapeutic targets for digestive system cancers (Review).
    Lei X; Hu X; Lu Q; Fu W; Sun W; Ma Q; Huang D; Xu Q
    Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36799184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology.
    Fernandes E; Sores J; Cotton S; Peixoto A; Ferreira D; Freitas R; Reis CA; Santos LL; Ferreira JA
    Theranostics; 2020; 10(11):4903-4928. PubMed ID: 32308758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy and potential predictive biomarkers in the treatment of neuroendocrine neoplasia.
    Xu G; Wang Y; Zhang H; She X; Yang J
    Future Oncol; 2021 Mar; 17(9):1069-1081. PubMed ID: 33136448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer.
    van Dijk N; Funt SA; Blank CU; Powles T; Rosenberg JE; van der Heijden MS
    Eur Urol; 2019 Mar; 75(3):435-444. PubMed ID: 30274701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
    Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
    Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic gene mutation signatures predict cancer type and prognosis in multiple cancers with pan-cancer 1000 gene panel.
    Wang HL; Liu PF; Yue J; Jiang WH; Cui YL; Ren H; Wang H; Zhuang Y; Liu Y; Jiang D; Dong Q; Zhang H; Mi JH; Xu ZM; Tian CJ; Zhang ZZ; Wang XW; Su MN; Lu W
    Cancer Lett; 2020 Feb; 470():181-190. PubMed ID: 31765737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biomarkers for neoplasmas in digestive organs].
    Iwasaki Y; Arai K; Katayanagi S; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1015-20. PubMed ID: 15272578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanobody-based therapeutics against colorectal cancer: Precision therapies based on the personal mutanome profile and tumor neoantigens.
    Moradi A; Pourseif MM; Jafari B; Parvizpour S; Omidi Y
    Pharmacol Res; 2020 Jun; 156():104790. PubMed ID: 32278043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists.
    Fusco N; Bosari S
    World J Gastroenterol; 2016 Sep; 22(35):7926-37. PubMed ID: 27672288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer.
    Aggarwal C; Thompson JC; Black TA; Katz SI; Fan R; Yee SS; Chien AL; Evans TL; Bauml JM; Alley EW; Ciunci CA; Berman AT; Cohen RB; Lieberman DB; Majmundar KS; Savitch SL; Morrissette JJD; Hwang WT; Elenitoba-Johnson KSJ; Langer CJ; Carpenter EL
    JAMA Oncol; 2019 Feb; 5(2):173-180. PubMed ID: 30325992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic analysis of molecular characterization and clinical relevance of m6A regulators in digestive system pan-cancers.
    Kou T; Chai R; Jin L; Bai Z; Yang Y; Zhao Y; Wu D; Zhang Z; Yang Y
    Exp Biol Med (Maywood); 2021 Sep; 246(18):2007-2018. PubMed ID: 34102905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profiles in foregut oncology.
    Sukharamwala P; Hennessey D; Wood T; Singh S; Ryan C; Rosemurgy A
    Cancer Genet; 2016 Dec; 209(12):537-553. PubMed ID: 27887938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.